Select country change
Shopping cart (0 , 0,00 ) Menu Search
Distributed product

SARS-CoV-2 Nucleocapsid protein (NP) High-sensitivity Quantitative ELISA

  • Regulatory status:RUO
  • Type:ELISA
  • Other names:SARS-CoV-2; COVID-19; nCoV; 2019-nCoV; Wuhan Coronavirus
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price


New 41A228R 96 wells (1 kit)
PubMed Product Details
Technical Data

Type

ELISA

Applications

Serum, Plasma, COVID-19

Sample Requirements

50 µl/well

Storage/Expiration

2–8°C

Calibration Range

31,25 - 2000 pg/ml

Intra-assay (Within-Run)

CV = 5%

Inter-assay (Run-to-Run)

CV = 6%

Spiking Recovery

91.5%

Summary

Features

  • For Research Use Only. Not for diagnostic procedures.
  • The total assay time is less than 3 hours.
  • For the detection and qualitative measurement of nucleocapsid protein (NP) of SARS-CoV-2 virus in human blood.
  • Assay format is 96 wells.
  • Components of the kit are provided ready to use or concentrated.

Research topic

COVID-19

Summary

Since December 2019, outbreak of SARS-CoV-2 (COVID-19) infection has become a major epidemic threat in China and brought back the attention of pathogenic coronavirus to the spotlight. Nucleocapsid protein (NP) is the most abundant protein on the helical nucleocapsid of coronaviruses, which envelopes the entire genomic RNA. NP also interacts with other viron structural proteins to play important roles during host cell entry and virus particle assembly and release. Anti-NP antibodies have been shown to be the earliest and the most predominant antibodies detectable in patient’s blood samples after coronavirus infection. Human anti-COVID-19 nucleocapsid protein (NP) IgM ELISA kit is a highly sensitive and specific ELISA kit for the precision detection and quantitative measurement of titres of anti-NP IgM class antibodies in human serum.

Related Products Docs